Cholinergic interactions of methysergide and cinanserin on isolated human smooth muscle.
D000109:Acetylcholine / Q000037:antagonists & inhibitors; D000813:Anilides / Q000494:pharmacology*; D001626:Bethanechol Compounds / Q000037:antagonists & inhibitors; D002217:Carbachol / Q000037:antagonists & inhibitors; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D002934:Cinnamates / Q000494:pharmacology*; D004064:Digestive System; D004336:Drug Antagonism; D004357:Drug Synergism; D006801:Humans; D066298:In Vitro Techniques; D008688:Methacholine Compounds / Q000037:antagonists & inhibitors; D008784:Methysergide / Q000494:pharmacology*; D009130:Muscle, Smooth / Q000187:drug effects*; D012702:Serotonin Antagonists; D001743:Urinary Bladder
D000813:Anilides; D001626:Bethanechol Compounds; D002800:Cholinesterase Inhibitors; D002934:Cinnamates; D008688:Methacholine Compounds; D012702:Serotonin Antagonists; D002217:Carbachol; D000109:Acetylcholine; D008784:Methysergide